565 related articles for article (PubMed ID: 11532038)
1. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
McCluggage WG; Sumathi VP; Maxwell P
Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
[TBL] [Abstract][Full Text] [Related]
2. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
3. IFITM1 Outperforms CD10 in Differentiating Low-grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus.
Busca A; Gulavita P; Parra-Herran C; Islam S
Int J Gynecol Pathol; 2018 Jul; 37(4):372-378. PubMed ID: 28700435
[TBL] [Abstract][Full Text] [Related]
4. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
Chu PG; Arber DA; Weiss LM; Chang KL
Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058
[TBL] [Abstract][Full Text] [Related]
5. Endometrial stromal neoplasms are immunoreactive with WT-1 antibody.
Sumathi VP; Al-Hussaini M; Connolly LE; Fullerton L; McCluggage WG
Int J Gynecol Pathol; 2004 Jul; 23(3):241-7. PubMed ID: 15213600
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.
Oliva E; Young RH; Amin MB; Clement PB
Am J Surg Pathol; 2002 Apr; 26(4):403-12. PubMed ID: 11914617
[TBL] [Abstract][Full Text] [Related]
7. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation.
Yilmaz A; Rush DS; Soslow RA
Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
9. Mixed endometrial stromal and smooth muscle tumors of the uterus: a clinicopathologic study of 15 cases.
Oliva E; Clement PB; Young RH; Scully RE
Am J Surg Pathol; 1998 Aug; 22(8):997-1005. PubMed ID: 9706980
[TBL] [Abstract][Full Text] [Related]
10. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG
Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555
[TBL] [Abstract][Full Text] [Related]
11. CD10 is a marker for normal and neoplastic endometrial stromal cells.
Toki T; Shimizu M; Takagi Y; Ashida T; Konishi I
Int J Gynecol Pathol; 2002 Jan; 21(1):41-7. PubMed ID: 11781522
[TBL] [Abstract][Full Text] [Related]
12. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors.
Nucci MR; O'Connell JT; Huettner PC; Cviko A; Sun D; Quade BJ
Am J Surg Pathol; 2001 Apr; 25(4):455-63. PubMed ID: 11257619
[TBL] [Abstract][Full Text] [Related]
13. Endometrial Stromal Sarcoma Arising from Endometrial Polyp: A Case Report.
Sato S; Ojima Y; Kanda M; Kizaki T; Ohara N
Kobe J Med Sci; 2018 Sep; 64(2):E36-E42. PubMed ID: 30381725
[TBL] [Abstract][Full Text] [Related]
14. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma.
Loddenkemper C; Mechsner S; Foss HD; Dallenbach FE; Anagnostopoulos I; Ebert AD; Stein H
Am J Surg Pathol; 2003 Nov; 27(11):1458-62. PubMed ID: 14576480
[TBL] [Abstract][Full Text] [Related]
15. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.
Agaimy A; Clarke BA; Kolin DL; Lee CH; Lee JC; McCluggage WG; Pöschke P; Stoehr R; Swanson D; Turashvili G; Beckmann MW; Hartmann A; Antonescu CR; Dickson BC
Am J Surg Pathol; 2022 Sep; 46(9):1298-1308. PubMed ID: 35575789
[TBL] [Abstract][Full Text] [Related]
16. Distinction of endometrial stromal sarcomas from 'hemangiopericytomatous' tumors using a panel of immunohistochemical stains.
Bhargava R; Shia J; Hummer AJ; Thaler HT; Tornos C; Soslow RA
Mod Pathol; 2005 Jan; 18(1):40-7. PubMed ID: 15309019
[TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical study of normal endometrial stroma and endometrial stromal neoplasms. Evidence for smooth muscle differentiation.
Franquemont DW; Frierson HF; Mills SE
Am J Surg Pathol; 1991 Sep; 15(9):861-70. PubMed ID: 1719832
[TBL] [Abstract][Full Text] [Related]
18. Use of myocardin in the classification of mesenchymal tumors of the uterus.
Liang J; Wu L; Xiao H; Li N; Wang H; Cheng C; Bai R; Zhao Y; Zheng H
Int J Gynecol Pathol; 2010 Jan; 29(1):55-62. PubMed ID: 19952936
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma.
Zhu XQ; Shi YF; Cheng XD; Zhao CL; Wu YZ
Gynecol Oncol; 2004 Jan; 92(1):71-9. PubMed ID: 14751141
[TBL] [Abstract][Full Text] [Related]
20. Metastatic endometrial stromal sarcoma of the lung: importance of immunohistochemical staining, clinical history and imaging studies.
Mentrikoski MJ; Zhao C; Zhang J; Wang HL; McMahon LA; Yang Q; Li F; Xu H
Biotech Histochem; 2012 Jan; 87(1):35-9. PubMed ID: 21838613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
